ArticleCancer diagnosis & prognosis

KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.

Brett Fleisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.